Heart drug tested as migraine shield in small trial
NCT ID NCT04853797
First seen Jan 09, 2026 · Last updated Jun 11, 2026 · Updated 28 times
Summary
This study looked at whether ivabradine, a heart medication, could prevent migraines triggered by a chemical called levcromakalim. 37 adults with migraine without aura took part. The goal was to see if ivabradine could reduce the number of migraine attacks caused by the trigger.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE WITHOUT AURA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Danish Headache Center
Glostrup Municipality, 2600, Denmark
-
Danish Headache Centre, Rigshospitalet-Glostrup
Glostrup, Region Sjælland, 2600, Denmark
Conditions
Explore the condition pages connected to this study.